This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Small-Cap Winners & Losers

Small-cap stocks drifted lower Tuesday, but a few health care names, in addition to Point.360 (PTSX), were able to climb on bouts of good news.

The media-production company rocketed 45% to $5.35 after saying DG FastChannel (DGIT) will buy its spot-advertising distribution operations, after the rest of Point.360's businesses are spun off to shareholders. DG will pay about one-fifth of a DG share for every Point.360 share, as well as $3 million in cash and up to $7 million in debt assumption. DG shares closed 3.3% higher at $17.50.

Span-America Medical Systems (SPAN - Get Report) of Greenville, S.C., was among the small-cap health leaders, jumping 16.5% to close at $19 after declaring a special cash dividend of $5 a share. Oncolytics Biotech (ONCY) closed up 17% at $2.28 after a recent colon-cancer study yielded positive results for the Canada-based company's main product, Reolysin, in combination with gemcitabine.

Moreover, Scolr Pharma (DDD - Get Report) said it expects to file a new drug application with the Food and Drug Administration for its extended-release ibuprofen product candidate in the latter half of 2008, given new positive clinical testing. Shares added 34 cents, or 13.8%, to close at $2.80.

Among the losers today was BSML (BSML), a maker of tooth-whitening products that slid 12.3% to $1.07 after the Nasdaq sent the company a delisting warning, citing inadequate stockholders' equity and market value, as well three straight years of losses.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
DGIT $12.07 -0.33%
PTSX $0.27 0.00%
DDD $18.95 1.77%
SPAN $18.23 -1.03%
AAPL $126.44 -0.13%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs